Bli medlem
Bli medlem

Du är här


Bactiguard Holding AB (publ): Nomination Committee appointed for the Annual General Meeting 2017

The Annual General Meeting of Bactiguard Holding AB (publ) will be
held on Thursday, 18 May 2017 in Botkyrka.

At the Annual General Meeting (AGM) in 2016, it was resolved that the
Nomination Committee in Bactiguard Holding AB (publ) shall consist of
four members. The chairman of the Board of Directors shall contact
the three largest shareholders of the Company, in terms of voting
power, pursuant to Euroclear Sweden AB's print out of the share
register on 31 August. Each of these three largest shareholders shall
be offered the opportunity, within reasonable time, to appoint a
member who, together with the chairman of the Board, constitutes the
Nomination Committee.

The Nomination Committee for the 2017 AGM in Bactiguard Holding AB
(publ) consists of the following members:

Stanley Brodén, Chairman of the Board of Directors
Jan Lombach, appointed by KK Invest AB
Thomas von Koch, appointed by Bactiguard B.V.
Christian Brunlid, appointed by Handelsbanken Fonder AB

The Nomination Committee will make proposals to the AGM 2017

the election of a Chairman for the AGM, the Chairman and other members
of the Board of Directors, as well as auditors. The Nomination
Committee will also make proposals regarding remuneration to the
Board of Directors, including any separate remuneration for committee
work, as well as remuneration to the auditors. Further, the
Nomination Committee will make a proposal regarding principles for
forming the Nomination Committee for the AGM in 2018.

Shareholders who wish to make proposals to the Nomination Committee
can do so by writing to the Nomination Committee under the following

Nomination Committee
Bactiguard Holding AB (publ)
Box 15
146 21 Tullinge

Proposals can also be sent by email to the following address:

In order for the Nomination Committee to be able to address proposals
in a constructive manner, they should have been received by January
15, 2017.

The proposals of the Nomination Committee will be presented in the
invitation to the AGM and at the company's website.

For further information, please contact:

Fredrik Järrsten, CFO, Mobile: +46 72 550 00 89

About Bactiguard
Bactiguard is a Swedish medtech company with a mission of preventing
healthcare associated infections, reducing the use of antibiotics and
saving lives by developing and supplying infection prevention
solutions for the healthcare industry. The company's patented coating
prevents healthcare associated infections by reducing bacterial
adhesion and growth on medical devices. Bactiguard®-coated urinary
catheters are market leading in the US and Japan, and in recent years
the company has developed its own product portfolio of catheters for
the urinary and respiratory tract and the blood stream. Bactiguard is
currently in a strong expansion phase, focused on new markets in the
Europe, Middle East, Asia, South America and Southern Africa. The
company has market presence in some 50 countries and has about 60
employees. Its headquarters is located in Stockholm and production
facilities in Sweden and Malaysia. Bactiguard is listed on Nasdaq
Stockholm. Read more about Bactiguard at


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.